RNA interference for subacute sclerosing panencephalitis.
Anlar
Banu
B
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D015316:Genetic Therapy / Q000379:methods*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D008457:Measles / Q000150:complications / Q000628:therapy; D034622:RNA Interference; D000069283:Rituximab; D013344:Subacute Sclerosing Panencephalitis / Q000209:etiology / Q000628:therapy*
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab